PACB R&D to Revenue
Pacific Biosciences Of California · R&D to Revenue
PACB R&D to Revenue
Latest reported60.81%period ending
PACB FY R&D/Revenue (888.40% → 60.81%)
Latest values, visible window
High-resolution chart · PNG
PACB r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 60.815% | |
| 87.6037% | |
| 93.3418% | |
| 150.424% | |
| 86.504% | |
| 81.3152% | |
| 65.6061% | |
| 79.6098% | |
| 69.8892% | |
| 74.5387% | |
| 65.1419% | |
| 79.5953% | |
| 160.4521% | |
| 183.2852% | |
| 224.67% | |
| 6,679.8686% | |
| 56,206.6667% | |
| 4,217.2031% | |
| 888.3957% |